Alshekhlee, Amer <br/><br/>
Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists.  [electronic resource] 

 -  Muscle & nerve  May 2010 
 - 723-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1097-4598 
<br/><br/><label>Standard No.: </label>10.1002/mus.21584  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Electrodiagnosis<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Immunosuppression Therapy--adverse effects<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Muscle Weakness--chemically induced<br/>Muscle, Skeletal--innervation<br/>Neural Conduction--drug effects<br/>Pain--chemically induced<br/>Paraparesis--chemically induced<br/>Peripheral Nerves--drug effects<br/>Polyradiculoneuropathy, Chronic Inflammatory Demyelinating--chemically induced<br/>Receptors, Tumor Necrosis Factor<br/>Recovery of Function--drug effects<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors